NCT00649051View on ClinicalTrials.gov

Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

January 31, 2003

Conditions
Healthy
Interventions
DRUG

Metolazone Tablets 2.5 mg

4x2.5mg, single dose fasting

DRUG

Zaroloxyn® Tablets 2.5 mg

4x2.5mg, single dose fasting

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY